$1.00
▼ -4.8% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
IceCure enrols initial patients for ProSense cryoablation trial in US
IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
ICCM earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±4.4% on average; after the most recent report on May 12, 2026 it moved +0.0%. ICCM beat the consensus EPS estimate in 2 of its last 3 reported quarters. The share price of $1.00 sits near its 52-week low.
Overview
52-week range
$0.96
$25
0% of range
Avg surprise (last 3)
+41.7%
Avg reaction (last 2)
-4.4%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.06 | $-0.03 | -100.0% | 0.0% | 0.0% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $0.06 | $-0.06 | +200.0% | — | — | earnings |
| Wed May 28, 2025 | Mar/2025 | $-0.06 | $-0.08 | +25.0% | — | -8.8% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for ICCM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ICCM earnings FAQ
How does ICCM stock usually react to earnings?
Across the last 2 reports the average next-day move was ±4.4%, up 0 times and down 2 times.